Literature DB >> 2470915

Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus.

R C Cheung1, W S Robinson, P L Marion, H B Greenberg.   

Abstract

In this article we report the first topological mapping of neutralizing epitopes of a hepadnavirus. Duck hepatitis B virus is the only hepadnavirus that can replicate and spread from cell to cell in tissue culture. As a result, it is possible to study hepadnaviral neutralization in vitro with this system. To accomplish this goal, we produced a library of monoclonal antibodies against duck hepatitis B virus and identified 12 neutralizing monoclonal antibodies by using an in vitro neutralization assay. The characteristics of six of the neutralizing monoclonal antibodies were further studied by epitope mapping. From the results of competitive binding studies, three distinct neutralizing epitopes were identified on the pre-S polypeptides and one was identified on the S polypeptide. Our findings suggest that antibodies to both the pre-S and S gene products of duck hepatitis B virus can neutralize viral infection in vitro. The pre-S gene product is at least as important as the S gene product in eliciting neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470915      PMCID: PMC250697     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  Application of recombinant DNA techniques in the development of viral vaccines.

Authors:  K Murray
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Topological mapping of murine leukemia virus proteins by competition-binding assays with monoclonal antibodies.

Authors:  M R Stone; R C Nowinski
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

4.  Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides.

Authors:  G R Dreesman; Y Sanchez; I Ionescu-Matiu; J T Sparrow; H R Six; D L Peterson; F B Hollinger; J L Melnick
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

5.  Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geese.

Authors:  P L Marion; J M Cullen; R R Azcárraga; M J Van Davelaar; W S Robinson
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

6.  Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes.

Authors:  A R Neurath; S B Kent; N Strick; K Parker; A M Courouce; M M Riottot; M A Petit; A Budkowska; M Girard; J Pillot
Journal:  Mol Immunol       Date:  1987-09       Impact factor: 4.407

7.  The development of novel hepatitis B vaccines.

Authors:  A J Zuckerman
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

8.  Stable antibody-producing murine hybridomas.

Authors:  R T Taggart; I M Samloff
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

9.  Characterization of a pre-S polypeptide on the surfaces of infectious avian hepadnavirus particles.

Authors:  J C Pugh; J J Sninsky; J W Summers; E Schaeffer
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

10.  Antigenic mapping of the surface proteins of rhesus rotavirus.

Authors:  R D Shaw; P T Vo; P A Offit; B S Coulson; H B Greenberg
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

View more
  10 in total

Review 1.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein.

Authors:  V Lambert; D Fernholz; R Sprengel; I Fourel; G Deléage; G Wildner; C Peyret; C Trépo; L Cova; H Will
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  The large surface protein of duck hepatitis B virus is phosphorylated in the pre-S domain.

Authors:  E V Grgacic; D A Anderson
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction.

Authors:  C Sunyach; C Rollier; M Robaczewska; C Borel; L Barraud; A Kay; C Trépo; H Will; L Cova
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

Authors:  M Triyatni; A R Jilbert; M Qiao; D S Miller; C J Burrell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection.

Authors:  S Tong; J Li; J R Wands
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor.

Authors:  U Klingmüller; H Schaller
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Naturally occurring point mutation in the C terminus of the polymerase gene prevents duck hepatitis B virus RNA packaging.

Authors:  Y Chen; W S Robinson; P L Marion
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles.

Authors:  J C Pugh; Q Di; W S Mason; H Simmons
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  A cell surface protein that binds avian hepatitis B virus particles.

Authors:  K Kuroki; R Cheung; P L Marion; D Ganem
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.